ACM
ARNA

Atika Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Atika Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-40,000
Closed -$1.83M – 95
2019
Q3 		$1.83M Buy
+40,000
New +$2.25M 0.39% 62

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Atika Capital Management's ARNA Position: Q4 2021 in Review

Atika Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 178,000 shares — an estimated $10.6M sold.

Atika Capital Management first reported a position in ARNA in Q3 2017 and held it in 17 quarters. The position peaked at $20.6M in Q3 2020. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Atika Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Atika Capital Management sold 178,000 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $10.6M.
  • Atika Capital Management first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and held it in 17 quarters.
  • Atika Capital Management's Arena Pharmaceuticals Inc position peaked at $20.6M in Q3 2020.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Atika Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.